Sinopharm Statistics Share Statistics Sinopharm has 626.33M
shares outstanding. The number of shares has increased by 0.88%
in one year.
Shares Outstanding 626.33M Shares Change (YoY) 0.88% Shares Change (QoQ) 0.37% Owned by Institutions (%) n/a Shares Floating 268.36M Failed to Deliver (FTD) Shares 171 FTD / Avg. Volume 1.29%
Short Selling Information The latest short interest is 4.39K, so 0% of the outstanding
shares have been sold short.
Short Interest 4.39K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is 8.77 and the forward
PE ratio is null.
Sinopharm's PEG ratio is
-0.4.
PE Ratio 8.77 Forward PE n/a PS Ratio 0.11 Forward PS 0 PB Ratio 0.78 P/FCF Ratio 6.45 PEG Ratio -0.4
Financial Ratio History Enterprise Valuation Sinopharm has an Enterprise Value (EV) of 331.16B.
EV / Sales 0.57 EV / EBITDA 15.43 EV / EBIT 28.68 EV / FCF 34.58
Financial Position The company has a current ratio of 1.39,
with a Debt / Equity ratio of 0.97.
Current Ratio 1.39 Quick Ratio 1.14 Debt / Equity 0.97 Debt / EBITDA 3.56 Debt / FCF 7.98 Interest Coverage 5.92
Financial Efficiency Return on Equity is 8.94% and Return on Invested Capital is 5.82%.
Return on Equity 8.94% Return on Assets 1.79% Return on Invested Capital 5.82% Revenue Per Employee $5.4M Profits Per Employee $65.14K Employee Count 108,217 Asset Turnover 1.49 Inventory Turnover 8.66
Taxes Income Tax 3.58B Effective Tax Rate 25.55%
Stock Price Statistics The stock price has increased by -6.09% in the
last 52 weeks. The beta is 0.59, so Sinopharm's
price volatility has been higher than the market average.
Beta 0.59 52-Week Price Change -6.09% 50-Day Moving Average 11.95 200-Day Moving Average 12.44 Relative Strength Index (RSI) 55.11 Average Volume (20 Days) 13,298
Income Statement In the last 12 months, Sinopharm had revenue of 584.51B
and earned 7.05B
in profits. Earnings per share was 11.3.
Revenue 584.51B Gross Profit 44.26B Operating Income 16.19B Net Income 7.05B EBITDA 21.47B EBIT 16.73B Earnings Per Share (EPS) 11.3
Full Income Statement Balance Sheet The company has 54.31B in cash and 76.39B in
debt, giving a net cash position of -22.07B.
Cash & Cash Equivalents 54.31B Total Debt 76.39B Net Cash -22.07B Retained Earnings 53.74B Total Assets 392.83B Working Capital 97.07B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 11.55B
and capital expenditures -1.97B, giving a free cash flow of 9.58B.
Operating Cash Flow 11.55B Capital Expenditures -1.97B Free Cash Flow 9.58B FCF Per Share 15.35
Full Cash Flow Statement Margins Gross margin is 7.57%, with operating and profit margins of 2.77% and 1.21%.
Gross Margin 7.57% Operating Margin 2.77% Pretax Margin 2.4% Profit Margin 1.21% EBITDA Margin 3.67% EBIT Margin 2.77% FCF Margin 1.64%
